'Any person can import Amphotericin B', says Delhi HC

New Delhi, May 27: In the reported shortage of Amphotericin B, used for treating black fungus, the Delhi High Court said that the drug Amphotericin B is required to save lives of people suffering all over the country and that the Central Government should consider complete waiver of import duties of the drug for a limited period.

 

 

This is after the Court in its statement said that any person can import Amphotericin B and if any import is made by any person, the same may be cleared by accepting the bond from the importer without actual payment of duty till a final decision on the said aspect is taken.

 

 

 

 

The Central government has given licence to five companies to ramp up the production of Liposomal Amphotericin B injections. After the PM had instructed officials to get this drug from anywhere it is available in the world, the Indian missions across the world have been involved in securing supplies of Amphotericin B (AmBisome) vials.

 

 

As per government data on Wednesday, India has recorded 11,717 cases of "Black Fungus" or Mucormycosis so far with Gujarat, Maharashtra, Andhra Pradesh, Madhya Pradesh and Telangana logging the highest number of rare fungal infection. While Maharashtra has reported 2,770 cases, Gujarat has logged 2,859 cases, Andhra Pradesh has registered 768 cases, Madhya Pradesh has 752 cases, and Telangana has 744 cases so far.

.

.